Below are the most recent publications written about "Longitudinal Studies" by people in Profiles.
-
O'Leary RM, Wingfield A, Lyons MJ, Franz CE, Kremen WS. Genetic and Environmental Contributions to Age-Related Hearing Loss: Results from a Longitudinal Twin Study. Trends Hear. 2025 Jan-Dec; 29:23312165251320156.
-
Ellis RA, Webber TK, Noble NC, Linnstaedt SD, Hinrichs R, Wiltshire C, Reda MH, Davie W, House SL, Beaudoin FL, An X, Neylan TC, Clifford GD, Germine LT, Rauch SL, Haran JP, Storrow AB, Lewandowski C, Musey PI, Hendry PL, Sheikh S, Punches BE, Pascual JL, Seamon MJ, Datner EM, Pearson C, Peak DA, Domeier RM, Rathlev NK, O'Neil BJ, Sergot P, Sanchez LD, Bruce SE, Joormann J, Kessler RC, Ressler KJ, Koenen KC, McLean SA, Stevens JS, Jovanovic T, Seligowski AV. Longitudinal Associations Between Peritraumatic Oestradiol and Fear Responding in Women and Men. Stress Health. 2025 Apr; 41(2):e3522.
-
Bell AJ, Ram S, Labaki WW, Murray S, Kazerooni EA, Galban S, Martinez FJ, Hatt CR, Wang JM, Ivanov V, McGettigan P, Khokhlovich E, Maiorino E, Suryadevara R, Boueiz A, Castaldi PJ, Mirkes EM, Zinovyev A, Gorban AN, Galban CJ, Han MK. Temporal Exploration of Chronic Obstructive Pulmonary Disease Phenotypes: Insights from the COPDGene and SPIROMICS Cohorts. Am J Respir Crit Care Med. 2025 Apr; 211(4):569-576.
-
Ogdie A, Reddy SM, Gillespie SH, Husni ME, Scher JU, Salomon-Escoto K, Kay J, Luedders BA, Curtis JR, Shields AJS, Chakravarty SD, Gong C, Walsh JA. Guselkumab versus golimumab in patients with active psoriatic arthritis and inadequate response to an initial tumor necrosis factor inhibitor: study protocol for EVOLUTION, a pragmatic, phase 3b, open-label, randomized, controlled effectiveness trial. Trials. 2025 Mar 19; 26(1):96.
-
Ding H, Ye Z, Paschalidis A, Bennett DA, Au R, Lin H. Dynamic lifetime risk prediction of Alzheimer's disease with longitudinal cognitive assessment measurements. Alzheimers Dement. 2025 Mar; 21(3):e70055.
-
Wellman RJ, Strong DR, O'Loughlin EK, Sylvestre MP, O'Loughlin JL. Adapting and applying tobacco dependence indicators to cannabis dependence. Drug Alcohol Depend. 2025 May 01; 270:112613.
-
Schneider LS, Freiesleben SD, van Breukelen G, Wang X, Brosseron F, Heneka MT, Teipel S, Kleineidam L, Stark M, Roy-Kluth N, Wagner M, Spottke A, Schmid M, Roeske S, Laske C, Munk MH, Perneczky R, Rauchmann BS, Buerger K, Janowitz D, D?zel E, Glanz W, Jessen F, Rostamzadeh A, Wiltfang J, Bartels C, Kilimann I, Schneider A, Fliessbach K, Priller J, Spruth EJ, Hellmann-Regen J, Peters O. Linking higher amyloid beta 1-38 (A?(1-38)) levels to reduced Alzheimer's disease progression risk. Alzheimers Dement. 2025 Feb; 21(2):e14545.
-
Riglea T, Wellman RJ, Sylvestre MP, Sabiston C, O'Loughlin J. Factor structure and measurement invariance of the GAD-7 across time, sex, and language in young adults. J Affect Disord. 2025 Apr 15; 375:359-365.
-
Griswold MK, Crawford SL, Person SD, Rosenberg L, Palmer JR, Cozier YC. Neighborhood Socioeconomic Status and Breastfeeding Initiation and Duration Among Primiparous Black Women. Breastfeed Med. 2025 May; 20(5):310-319.
-
Al Gburi M, Mazzola M, Absinta M, Gait?n MI, Reich DS, Dundamadappa SK, Hemond CC. Paramagnetic rim lesion formation is predicted by the initial gadolinium-enhancing lesion diameter. Mult Scler. 2025 Mar; 31(3):263-277.